vs
Side-by-side financial comparison of Childrens Place, Inc. (PLCE) and Royalty Pharma plc (RPRX). Click either name above to swap in a different company.
Royalty Pharma plc is the larger business by last-quarter revenue ($622.0M vs $339.5M, roughly 1.8× Childrens Place, Inc.). Royalty Pharma plc runs the higher net margin — 34.4% vs -1.3%, a 35.7% gap on every dollar of revenue. On growth, Royalty Pharma plc posted the faster year-over-year revenue change (4.8% vs -13.0%). Over the past eight quarters, Royalty Pharma plc's revenue compounded faster (4.6% CAGR vs -13.6%).
The Children’s Place is a retailer of clothing for children. It sells its products primarily under its proprietary brands The Children’s Place, Gymboree, Sugar & Jade, PJ Place and Crazy 8. The company has about 525 stores in the U.S., Canada and Puerto Rico, and also sells via two online outlets and through five franchise partners in 15 countries. Its product line includes tops, skirts, dresses, jackets, shoes, bottoms, sleepwear and backpacks. The Children’s Place is headquartered in Secauc...
Acceleron Pharma, Inc. is an American clinical stage biopharmaceutical company based in Cambridge, Massachusetts with a broad focus on developing medicines that regulate the transforming growth factor beta (TGF-β) superfamily of proteins, which play fundamental roles in the growth and repair of cells and tissues such as red blood cells, muscle, bone, and blood vessels.
PLCE vs RPRX — Head-to-Head
Income Statement — Q3 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $339.5M | $622.0M |
| Net Profit | $-4.3M | $214.2M |
| Gross Margin | 33.1% | — |
| Operating Margin | 1.1% | 62.4% |
| Net Margin | -1.3% | 34.4% |
| Revenue YoY | -13.0% | 4.8% |
| Net Profit YoY | -121.5% | 2.9% |
| EPS (diluted) | $-0.19 | $0.49 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $339.5M | $622.0M | ||
| Q3 25 | $298.0M | $609.3M | ||
| Q2 25 | $242.1M | $578.7M | ||
| Q1 25 | $408.6M | $568.2M | ||
| Q4 24 | $390.2M | $593.6M | ||
| Q3 24 | $319.7M | $564.7M | ||
| Q2 24 | $267.9M | $537.3M | ||
| Q1 24 | $455.0M | $568.0M |
| Q4 25 | $-4.3M | $214.2M | ||
| Q3 25 | $-5.4M | $288.2M | ||
| Q2 25 | $-34.0M | $30.2M | ||
| Q1 25 | $-8.0M | $238.3M | ||
| Q4 24 | $20.1M | $208.2M | ||
| Q3 24 | $-32.1M | $544.0M | ||
| Q2 24 | $-37.8M | $102.0M | ||
| Q1 24 | $-128.8M | $4.8M |
| Q4 25 | 33.1% | — | ||
| Q3 25 | 34.0% | — | ||
| Q2 25 | 29.2% | — | ||
| Q1 25 | 28.5% | — | ||
| Q4 24 | 35.5% | — | ||
| Q3 24 | 35.0% | — | ||
| Q2 24 | 34.6% | — | ||
| Q1 24 | 21.8% | — |
| Q4 25 | 1.1% | 62.4% | ||
| Q3 25 | 1.4% | 70.1% | ||
| Q2 25 | -10.0% | 36.3% | ||
| Q1 25 | 1.7% | 94.0% | ||
| Q4 24 | 7.5% | 60.9% | ||
| Q3 24 | -6.8% | — | ||
| Q2 24 | -10.4% | 50.2% | ||
| Q1 24 | -13.6% | -13.0% |
| Q4 25 | -1.3% | 34.4% | ||
| Q3 25 | -1.8% | 47.3% | ||
| Q2 25 | -14.1% | 5.2% | ||
| Q1 25 | -2.0% | 41.9% | ||
| Q4 24 | 5.1% | 35.1% | ||
| Q3 24 | -10.0% | 96.3% | ||
| Q2 24 | -14.1% | 19.0% | ||
| Q1 24 | -28.3% | 0.8% |
| Q4 25 | $-0.19 | $0.49 | ||
| Q3 25 | $-0.24 | $0.67 | ||
| Q2 25 | $-1.57 | $0.07 | ||
| Q1 25 | $-0.60 | $0.55 | ||
| Q4 24 | $1.57 | $0.46 | ||
| Q3 24 | $-2.51 | $1.21 | ||
| Q2 24 | $-2.98 | $0.23 | ||
| Q1 24 | $-10.24 | $0.01 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $7.3M | $618.7M |
| Total DebtLower is stronger | $107.4M | $9.0B |
| Stockholders' EquityBook value | $-8.6M | $9.7B |
| Total Assets | $762.5M | $19.6B |
| Debt / EquityLower = less leverage | — | 0.92× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $7.3M | $618.7M | ||
| Q3 25 | $7.8M | $938.9M | ||
| Q2 25 | $5.7M | $631.9M | ||
| Q1 25 | $5.3M | $1.1B | ||
| Q4 24 | $5.7M | $929.0M | ||
| Q3 24 | $9.6M | $950.1M | ||
| Q2 24 | $13.0M | $1.8B | ||
| Q1 24 | $13.6M | $843.0M |
| Q4 25 | $107.4M | $9.0B | ||
| Q3 25 | $107.2M | $8.9B | ||
| Q2 25 | $107.0M | $8.0B | ||
| Q1 25 | $166.0M | $7.6B | ||
| Q4 24 | $165.7M | $7.6B | ||
| Q3 24 | $165.4M | $7.6B | ||
| Q2 24 | $166.6M | $7.6B | ||
| Q1 24 | $49.8M | $6.1B |
| Q4 25 | $-8.6M | $9.7B | ||
| Q3 25 | $-4.9M | $9.6B | ||
| Q2 25 | $1.4M | $9.5B | ||
| Q1 25 | $-59.4M | $9.8B | ||
| Q4 24 | $-49.6M | $10.3B | ||
| Q3 24 | $-68.9M | $10.3B | ||
| Q2 24 | $-34.9M | $9.8B | ||
| Q1 24 | $-9.0M | $9.9B |
| Q4 25 | $762.5M | $19.6B | ||
| Q3 25 | $805.1M | $19.3B | ||
| Q2 25 | $779.6M | $18.3B | ||
| Q1 25 | $747.6M | $17.6B | ||
| Q4 24 | $888.8M | $18.2B | ||
| Q3 24 | $921.4M | $18.0B | ||
| Q2 24 | $848.3M | $17.7B | ||
| Q1 24 | $800.3M | $16.1B |
| Q4 25 | — | 0.92× | ||
| Q3 25 | — | 0.93× | ||
| Q2 25 | 75.63× | 0.84× | ||
| Q1 25 | — | 0.78× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 0.74× | ||
| Q2 24 | — | 0.78× | ||
| Q1 24 | — | 0.62× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $6.2M | $827.1M |
| Free Cash FlowOCF − Capex | $-3.4M | — |
| FCF MarginFCF / Revenue | -1.0% | — |
| Capex IntensityCapex / Revenue | 2.8% | — |
| Cash ConversionOCF / Net Profit | — | 3.86× |
| TTM Free Cash FlowTrailing 4 quarters | $39.5M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $6.2M | $827.1M | ||
| Q3 25 | $-30.5M | $702.6M | ||
| Q2 25 | $-43.0M | $364.0M | ||
| Q1 25 | $121.3M | $596.1M | ||
| Q4 24 | $-44.2M | $742.5M | ||
| Q3 24 | $-83.9M | $703.6M | ||
| Q2 24 | $-110.8M | $658.2M | ||
| Q1 24 | $135.4M | $664.6M |
| Q4 25 | $-3.4M | — | ||
| Q3 25 | $-31.9M | — | ||
| Q2 25 | $-46.4M | — | ||
| Q1 25 | $121.2M | — | ||
| Q4 24 | $-47.7M | — | ||
| Q3 24 | $-91.7M | — | ||
| Q2 24 | $-115.5M | — | ||
| Q1 24 | $132.2M | — |
| Q4 25 | -1.0% | — | ||
| Q3 25 | -10.7% | — | ||
| Q2 25 | -19.2% | — | ||
| Q1 25 | 29.7% | — | ||
| Q4 24 | -12.2% | — | ||
| Q3 24 | -28.7% | — | ||
| Q2 24 | -43.1% | — | ||
| Q1 24 | 29.1% | — |
| Q4 25 | 2.8% | — | ||
| Q3 25 | 0.5% | — | ||
| Q2 25 | 1.4% | — | ||
| Q1 25 | 0.0% | — | ||
| Q4 24 | 0.9% | — | ||
| Q3 24 | 2.4% | — | ||
| Q2 24 | 1.8% | — | ||
| Q1 24 | 0.7% | — |
| Q4 25 | — | 3.86× | ||
| Q3 25 | — | 2.44× | ||
| Q2 25 | — | 12.06× | ||
| Q1 25 | — | 2.50× | ||
| Q4 24 | -2.20× | 3.57× | ||
| Q3 24 | — | 1.29× | ||
| Q2 24 | — | 6.45× | ||
| Q1 24 | — | 139.10× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
PLCE
| The Childrens Place US | $307.4M | 91% |
| The Childrens Place International | $32.1M | 9% |
| Gift Cards | $1.7M | 1% |
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
